Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Innoviva (INVA) EPS (Weighted Average and Diluted) (2016 - 2026)

Innoviva filings provide 15 years of EPS (Weighted Average and Diluted) readings, the most recent being $1.08 for Q3 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 5300.0% to $1.08 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.13, a 24.18% increase, with the full-year FY2025 number at $3.3, up 816.67% from a year prior.
  • EPS (Weighted Average and Diluted) hit $1.08 in Q3 2025 for Innoviva, up from $0.77 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.8 in Q3 2022 to a low of -$0.74 in Q1 2025.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $0.46 (2024), compared with a mean of $0.54.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): plummeted 2850.0% in 2024 and later soared 5300.0% in 2025.
  • Innoviva's EPS (Weighted Average and Diluted) stood at $0.9 in 2021, then surged by 211.11% to $2.8 in 2022, then tumbled by 65.0% to $0.98 in 2023, then tumbled by 97.96% to $0.02 in 2024, then soared by 5300.0% to $1.08 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $1.08 (Q3 2025), $0.77 (Q2 2025), and -$0.74 (Q1 2025) per Business Quant data.